Billionaires Holding ACAD

BILLIONAIRE ALLOCATION SHARES OWNED (M) % CO AVG. COST RETURN

FUNDAMENTALS

  • N/A
    PE

  • 0.0
    Yield

  • 99.8M
    Shares Outstanding

  • 4.11B
    Market Cap

News & Insights

ABOUT

ACAD

ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in neurological and related central nervous system disorders. The company has a pipeline of product candidates led by Pimavanserin th...

Introducing The New Elon Musk Strategy

NEWS

iBillionaire Joins Forces With IBM Watson

READ MORE